UROGEN PHARMA LTD Share Price Today: Live Updates & Key Insights
UROGEN PHARMA LTD share price today is $17.96, up -5.22%. The stock opened at $18.65 against the previous close of $18.59, with an intraday high of $18.775 and low of $17.5.
UROGEN PHARMA LTD Share Price Chart
UROGEN PHARMA LTD
UROGEN PHARMA LTD Share Price Performance
UROGEN PHARMA LTD Institutional Holdings
UROGEN PHARMA LTD Market Status
UROGEN PHARMA LTD Fundamentals
Market Cap 857.78 M
PB Ratio 19.2691
PE Ratio 0.0
Enterprise Value 866.63 M
Total Assets 200.46 M
Volume 975333
UROGEN PHARMA LTD Company Financials
About UROGEN PHARMA LTD & investment objective
Company Information UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a sustained-release formulation of mitomycin for the treatment of non-muscle invasive bladder cancer (NMIBC); and Jelmyto for pyelocalyceal solutions. The company's lead product candidates are UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that is in phase 3 of clinical trial for pyelocalyceal solution designed for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk NMIBC. It is also developing UGN-301, UGN-301+UGN 201, and UGN-301+gemcitabine that are in phase 1 of clinical trial for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 and UGN-104. UroGen Pharma Ltd. was incorporated in 2004 and is headquartered in Princeton, New Jersey.
Organisation Biotechnology
Employees 291
Industry Biotechnology
CEO Ms. Elizabeth A. Barrett
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
UROGEN PHARMA LTD FAQs
What is the share price of UROGEN PHARMA LTD today?
The current share price of UROGEN PHARMA LTD is $17.96.
Can I buy UROGEN PHARMA LTD shares in India?
Yes, Indian investors can buy UROGEN PHARMA LTD shares by opening an international trading and demat account with Motilal Oswal.
How to buy UROGEN PHARMA LTD shares in India?
You can easily invest in UROGEN PHARMA LTD shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy UROGEN PHARMA LTD shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of UROGEN PHARMA LTD.
Can I buy fractional shares of UROGEN PHARMA LTD?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of UROGEN PHARMA LTD?
UROGEN PHARMA LTD has a market cap of $857.78 M.
In which sector does UROGEN PHARMA LTD belong?
UROGEN PHARMA LTD operates in the Biotechnology sector.
What documents are required to invest in UROGEN PHARMA LTD stocks?
To invest, you typically need:
What is the PE and PB ratio of UROGEN PHARMA LTD?
The PE ratio of UROGEN PHARMA LTD is N/A and the PB ratio is 19.27.